TrialClinical genitourinary cancer2018

Comprehensive Genomic Profiling of Metastatic Tumors in a Phase 2 Biomarker Study of Everolimus in Advanced Renal Cell Carcinoma.

Xin Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.